How does the body regulate the activity of insulin-producing cells in order to react quickly to changing conditions? Researchers have investigated this question.
The FDA has approved a companion diagnostic to determine if patients with HR-positive, HER2-ultralow metastatic breast cancer are eligible for T-DXd treatment.
A study from Weill Cornell Medicine and the University of Virginia suggests that neuroactive steroids derived from progesterone may predict the risk of postpartum depression (PPD). Women with altered ...